Correvio Announces Chief Executive Officer Succession Plan and Other Board and Executive Changes
NASDAQ: CORV TSX: CORV
- Mark H.N. Corrigan, MD to Succeed William Hunter, MD as Chief Executive Officer by the End of the First Quarter 2019 -
- Dr. Hunter to Remain a Member of the Board of Directors -
- Chief Financial Officer, Justin Renz, Appointed President -
- Vanda De Cian, MD, to Join the Board of Directors -
Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a revenue-generating, specialty pharmaceutical company focused on commercial...